It is important to note that activated T helper cells (CD4+CD69+) may include cells with Th1 (‘inflammatory’ / anti-tumor) or Th2-type (less inflammatory/humoral-type response) phenotypes, and the relevance of enhanced or suppressive immunity may vary with type of cancer and with the stage of tumor development [26]. The gene discussed is CD69; the disease is neoplasm.